Relationship Between Metabolic Profiles and Chronic Diseases and Neoplasms
Launched by FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jul 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how metabolic disorders, which are conditions that affect how our bodies process food and energy, may be linked to chronic diseases (like diabetes or heart disease) and tumors (abnormal growths in the body). The researchers want to understand the connections between these metabolic issues and the development of chronic diseases and tumors. By observing different metabolic factors in participants, they hope to uncover how these factors might contribute to the onset and progression of these health problems.
To participate in this study, individuals must be 18 years or older and have completed a health screening. The trial is currently recruiting participants of all genders. Those who are pregnant or under 18 years old are not eligible. Participants can expect to share information about their health and undergo tests that help researchers learn more about the connections between metabolism and chronic diseases. This study aims to shed light on important health issues that affect many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult aged ≥18 years old
- • Completed health screening
- Exclusion Criteria:
- • aged \<18 years old
- • pregnancy
About First Affiliated Hospital Of Chongqing Medical University
The First Affiliated Hospital of Chongqing Medical University is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and education. As a prominent sponsor of clinical trials, the hospital is committed to conducting high-quality, ethically-driven studies that contribute to the understanding and treatment of various medical conditions. With a robust infrastructure and a team of experienced researchers and healthcare professionals, the institution fosters collaboration across disciplines to enhance patient care and improve health outcomes. Its strategic focus on translational medicine underscores the hospital's role in bridging the gap between laboratory discoveries and clinical applications, ultimately benefiting patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, Chongqing, China
Patients applied
Trial Officials
Qin Duan, doctor
Study Director
The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported